Unveiling the Molecular Chemistry Behind PAAG’s Lasting Presence in Arthritic Knees
Discover how polyacrylamide gel (PAAG) offers promising long-lasting relief for knee osteoarthritis (OA). Unlike traditional treatments, PAAG is a synthetic gel designed to act as a durable shock absorber, mimicking healthy cartilage when injected into the knee. Thanks to strong molecular interactions, PAAG remains stable and anchored inside the joint, providing sustained pain relief and improved mobility for up to 24 months, especially in older patients with mild OA. This innovative therapy represents a significant advance in targeting the root challenges of osteoarthritis, with ongoing research exploring its long-term safety and effectiveness. Learn how PAAG is paving the way for improved OA management.
One Jab, Two Years: Exploring the 24-Month Pain Relief of PAAG for Knee Osteoarthritis
Discover how polyacrylamide hydrogel (PAAG) injections offer up to two years of pain relief for knee osteoarthritis (OA) sufferers. Unlike traditional treatments, PAAG acts as a long-lasting joint cushion, minimizing pain and enhancing mobility. Recent studies highlight best results in older adults, those with lower BMI, non-diabetics, and patients treating both knees. This innovative, minimally invasive therapy reduces the need for frequent procedures and could delay or prevent knee replacement surgery. Learn more about how PAAG could transform knee OA management and improve quality of life for many patients.
